Montelukast Prescribing at TREGENNA GROUP PRACTICE
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
913
Total Quantity
25.0K
NHS Cost
£1.1K
vs National Avg
+33.3%
TREGENNA GROUP PRACTICE prescribed 913 items of Montelukast over the last 12 months at a cost of £1,142 to the NHS. This is 33.3% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jun 2026
76
Jun 2026
67
Jun 2026
75
Jun 2026
66
Jun 2026
72
Jun 2026
77
Jun 2026
82
Jun 2026
94
Jun 2026
81
Jun 2026
71
Jun 2026
78
Jun 2026
74
Prescribing Details
| Total Items | 913 |
|---|---|
| Total Quantity | 25,020 |
| Total NHS Cost | £1,142 |
| Presentations | 3 different forms |
| vs National Average | +33.3% |
Montelukast Prescribing Comparison
| This practice | 913 items |
|---|---|
| National average per practice | 685 items |
| Difference | +33.3% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.